HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

about

AIDS, memory and the history of medicine: musings on the Canadian response.TALEN-mediated modification of the bovine genome for large-scale production of human serum albumin

P2860

Q33934729-4AC3EF82-21B7-4B03-82BC-DA5E22D0CC4E Q35107776-DB6B007A-86E6-48CE-BC80-C057AC612551

P2860

HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

Item

http://www.wikidata.org/entity/Q40761966

description

1990 nî lūn-bûn

@nan

1990年の論文

@ja

1990年学术文章

@wuu

1990年学术文章

@zh-cn

1990年学术文章

@zh-hans

1990年学术文章

@zh-my

1990年学术文章

@zh-sg

1990年學術文章

@yue

1990年學術文章

@zh

1990年學術文章

@zh-hant

name

HIV transmission to patients w ...... r-screened factor concentrate.

@en

type

Item

label

HIV transmission to patients w ...... r-screened factor concentrate.

@en

prefLabel

HIV transmission to patients w ...... r-screened factor concentrate.

@en

P1476

HIV transmission to patients w ...... r-screened factor concentrate.

@en

P2093

Growe GH

http://www.w3.org/2001/XMLSchema#string

Lawrence DN

http://www.w3.org/2001/XMLSchema#string

O'Shaughnessy MV

http://www.w3.org/2001/XMLSchema#string

Palmer RW

http://www.w3.org/2001/XMLSchema#string

Remis RS

http://www.w3.org/2001/XMLSchema#string

Schechter MT

http://www.w3.org/2001/XMLSchema#string

Tsoukas C

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.

HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort.

Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

Primary human T-lymphotropic virus type III infection.

Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.

Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.

Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations.

HTLV-III seroconversion associated with heat-treated factor VIII concentrate.

Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate.

P304

1247-1254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P577

1990-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2111726

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia B

HIV transmission

P932

1452559

http://www.w3.org/2001/XMLSchema#string

HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

about

P2860

P2860

HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932